Multivalent Probes in Molecular Imaging: Reality or Future?
- PMID: 33436332
- DOI: 10.1016/j.molmed.2020.12.006
Multivalent Probes in Molecular Imaging: Reality or Future?
Erratum in
-
Multivalent probes in molecular imaging: reality or future?: (Trends in Molecular Medicine, 27:4 p:379-393, 2021).Trends Mol Med. 2024 May 22:S1471-4914(24)00125-4. doi: 10.1016/j.molmed.2024.05.003. Online ahead of print. Trends Mol Med. 2024. PMID: 38782679 No abstract available.
Abstract
The rapidly developing field of molecular medical imaging focuses on specific visualization of (patho)physiological processes through the application of imaging agents (IAs) in multiple clinical modalities. Although our understanding of the principles underlying efficient IAs design has increased tremendously, many IAs still show poor in vivo imaging performance because of low binding affinity and/or specificity. These limitations can be addressed by taking advantage of multivalency, in which multiple copies of a ligand are employed to strengthen the interaction. We critically address specific challenges associated with the application of multivalent compounds in molecular imaging, and we give directions for a stepwise approach to the design of multivalent imaging probes to improve their target binding and pharmacokinetics (PK) for improved diagnostic potential.
Keywords: avidity; binding affinity; imaging probes; multivalency, molecular imaging.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Multivalent glibenclamide to generate islet specific imaging probes.Biomaterials. 2016 Jan;75:1-12. doi: 10.1016/j.biomaterials.2015.10.006. Epub 2015 Oct 9. Biomaterials. 2016. PMID: 26474038
-
Molecular Imaging of Aminopeptidase N in Cancer and Angiogenesis.Contrast Media Mol Imaging. 2018 Jun 25;2018:5315172. doi: 10.1155/2018/5315172. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 30046296 Free PMC article. Review.
-
Resolving antibody-peptide complexes with different ligand stoichiometries reveals a marked affinity enhancement through multivalency.Talanta. 2013 Oct 15;115:394-400. doi: 10.1016/j.talanta.2013.05.070. Epub 2013 Jun 5. Talanta. 2013. PMID: 24054608
-
Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag.J Control Release. 2014 Jul 28;186:32-40. doi: 10.1016/j.jconrel.2014.04.053. Epub 2014 May 9. J Control Release. 2014. PMID: 24815420
-
Activatable Multimodal Probes for In Vivo Imaging and Theranostics.Angew Chem Int Ed Engl. 2022 Dec 12;61(50):e202209512. doi: 10.1002/anie.202209512. Epub 2022 Oct 27. Angew Chem Int Ed Engl. 2022. PMID: 36151870 Review.
Cited by
-
RNA nanostructures for targeted drug delivery and imaging.RNA Biol. 2024 Jan;21(1):1-19. doi: 10.1080/15476286.2024.2328440. Epub 2024 Mar 31. RNA Biol. 2024. PMID: 38555519 Free PMC article. Review.
-
Lessons learned in application driven imaging agent design for image-guided surgery.Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3040-3054. doi: 10.1007/s00259-024-06791-x. Epub 2024 Jun 20. Eur J Nucl Med Mol Imaging. 2024. PMID: 38900308 Free PMC article. Review.
-
The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.RSC Med Chem. 2024 Apr 19;15(6):2018-2029. doi: 10.1039/d4md00073k. eCollection 2024 Jun 19. RSC Med Chem. 2024. PMID: 38911160 Free PMC article.
-
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1136-1147. doi: 10.1007/s00259-021-05559-x. Epub 2021 Sep 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 34559266 Free PMC article.
-
Smart Biomimetic Nanozymes for Precise Molecular Imaging: Application and Challenges.Pharmaceuticals (Basel). 2023 Feb 7;16(2):249. doi: 10.3390/ph16020249. Pharmaceuticals (Basel). 2023. PMID: 37259396 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources